This is indeed the case in some tumours, where restoration of sFRP1 expression inhibits both β-catenin/TCF activity and cancer cell growth (Suzuki et al, 2004; Nojima et al, 2007; Shih et al, 2007). The gene discussed is SFRP1; the disease is cancer.